MASS SPECTROMETRY AS A TOOL FOR MINIMAL RESIDUAL DISEASE DETECTION IN THE BLOOD OF MYELOMA PATIENTS

Authors: J.F.M. Jacobs

Published: 2023-05-10

DOI: 10.1097/01.hs9.0000936072.38361.07

Source: Full article

---

Abstract

No abstract found.